论文信息 - Results of a multicenter phase II trial for older patients with c‐Kit‐positive acute myeloid leukemia (AML) and high‐risk myelodysplastic syndrome (HR‐MDS) using low‐dose Ara‐C and Imatinib - 字舞流文

Results of a multicenter phase II trial for older patients with c‐Kit‐positive acute myeloid leukemia (AML) and high‐risk myelodysplastic syndrome (HR‐MDS) using low‐dose Ara‐C and Imatinib

H. Döhner | H. Kantarjian | J. Cortes | F. Heidel | C. Huber | T. Fischer | F. Rücker | W. Aulitzky | T. Kindler | L. Letvak | F. Rücker